These findings provide compelling evidence that SLC7A11 plays a critical role in regulating lipid peroxidation and maintaining redox homeostasis in the SN of diabetic rats following 6‐OHDA administration, underscoring its potential as a therapeutic target for PD patients with comorbid diabetes. Here, SLC7A11 is linked to Parkinson disease.